AzTrials
AzTrials

Hypermobile EDS (hEDS)NCT07626957

Hamstring Strengthening in Hypermobile Conditions

A study testing Progressive resistance exercise with an emphasis on eccentric hamstring loading. in people with Hypermobile EDS (hEDS) and Hypermobile Ehlers-Danlos Syndrome, run by University of Calgary at 1 site in Canada.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to determine how strengthening the hamstring muscles affects the knee joint in people living with hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS). Read more about this study

Who is it for?
Ages 18 to 55 years, women only
What is being tested?
Progressive resistance exercise with an emphasis on eccentric hamstring loading.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
1 Jun 2026to 1 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Reported diagnosis of HSD or hEDS by a physician
  • Meet the 2017 International Diagnostic Criteria for HSD and hEDS
  • Clearance to participant in exercise participation, determined using the Get Active Questionnaire

Who cannot join

  • Other acquired or hereditary connective tissue disorder (i.e., rheumatoid arthritis, Marfan syndrome, etc.)
  • Currently experiencing daily knee pain
  • Prior knee injury or surgery
  • Intra-articular knee injection in the last 12 months
  • Currently pregnant

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Canada1 site
  • University of Calgary - Foothills Campus

    Calgary, Alberta, T2N 4N1

    Ranita Manocha, bettermobilitylab@ucalgary.ca

    Ranita Manocha, MD, MSc

Other trials in Canada

About this study

Official title: Effects and Feasibility of Eccentric Hamstring Strengthening in Hypermobility Spectrum Disorders and Hypermobile Ehlers-Danlos Syndrome

The goal of this clinical trial is to determine how strengthening the hamstring muscles affects the knee joint in people living with hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS). The main questions it aims to answer are:

  • Does hamstring strengthening reduce the looseness of the knee joint in HSD/hEDS?
  • Does hamstring strengthening improve clinical outcomes like pain in people living with HSD/hEDS?

Participants will:

  • Attend two exercise classes per week for 12 weeks.
  • Visit the laboratory every 4-6 weeks for testing.
Read the detailed description

Hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) affect 1 in 500 people, predominantly females. While exercise is known to be beneficial for HSD/hEDS, the effect of eccentric exercise on passive joint stability, the functional capacity to perform daily activities, and quality of life remains unknown. This clinical trial aims to determine the effects of a 12-week eccentric hamstring strengthening intervention for females with HSD/hEDS on knee joint laxity, performance during walking and stair climbing, and quality of life. This study will have important implications for understanding the impacts of exercise in HSD/hEDS. This can then inform clinical guidance and recommendations around lower limb exercise for this population.

Being tested
Progressive resistance exercise with an emphasis on eccentric hamstring loading.
Keywords
Exercise, Female, Knee, Joint Laxity, Hypermobility, Joint Stiffness, Ehlers-Danlos Syndrome, Hypermobile Ehlers-Danlos Syndrome, Hypermobility Spectrum Disorders, strengthening, eccentric
Medical subject headings
Ehlers-Danlos syndrome type 3, Motor Activity, Joint Instability, Ehlers-Danlos Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Progressive resistance exercise with an emphasis on eccentric hamstring loading.Behavioural

    Also called Exercise, Progressive Resistance Training, Eccentric Exercise

    The exercise intervention consists of a 12-week supervised lower limb strengthening program focused on eccentric hamstring loading. This program is adapted from a lower limb progressive resistance training protocol that was well-tolerated and effective in people with HSD/hEDS. Each exercise session will start with a 10-minute aerobic warm up. This will be followed by the lower limb strengthening exercises, and a 5-minute aerobic cooldown. The lower limb exercises will include forward lunges and seated machine weights (leg press, leg extension, leg curl, calf raise). At weeks 6-11, eccentric hamstring loading will be initiated by utilizing the 2:1 technique of two limbs performing concentric action at once and then a single limb performing the eccentric action in a seated leg curl machine. This is an established eccentric loading protocol for the hamstring muscle group.

Study groups in NCT07626957
Study groupRoleWhat they receive
Eccentric hamstring exerciseExperimentalAll participants will complete a 12-week supervised lower limb strengthening program focused on eccentric hamstring loading. Participants will complete two training sessions per week with at least 48 hours between training sessions. Multiple classes will be offered each week to increase participation opportunity, with morning classes (8-9am) and evening classes (6-7pm) being offered on Mondays and Thursdays. Each class will be led by the same trained kinesiologist and cover the same training protocol within a given week, regardless of the day or time.
Receives: Behavioral: Progressive resistance exercise with an emphasis on eccentric hamstring loading.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knee Joint Laxity

    Anterior knee joint laxity measured in millimeters using a KT-2000 Knee Ligament Arthrometer at 67N, 89N, and 133N of applied force, as well as maximum displacement. Posterior knee joint laxity will be assessed at 67N of applied force. Changes in knee joint laxity at each level of applied force will be assessed from baseline to 4, 8, 12, 18, and 24 weeks after baseline.

    Measured: Measured at all 6 outcome assessments (baseline, 4, 8, 12, 18, and 24 weeks).

Secondary outcomes (8)
  1. Knee Joint Stiffness

    Anterior knee joint stiffness calculated from the change in displacement divided by the change in force from 0N to 67N, 67N to 89N, and 89N to 133N. Posterior knee joint stiffness will be calculated between 0N and 67N of force. Changes in stiffness will be assessed from baseline to 4, 8, 12, 18, and 24 weeks after baseline.

    Measured: Measured at all 6 outcome assessments (baseline, 4, 8, 12, 18, and 24 weeks).

  2. Isokinetic eccentric knee flexion strength

    Isokinetic eccentric knee flexion strength at 60 degrees per second will be measured using a Biodex Dynamometer. Change in eccentric knee flexion strength will be assessed from baseline to 4, 8, 12, 18, and 24 weeks after baseline.

    Measured: Measured at all 6 outcome assessments (baseline, 4, 8, 12, 18, and 24 weeks).

  3. Isokinetic concentric knee flexion strength

    Isokinetic concentric knee flexion strength at 60 degrees per second will be measured using a Biodex dynamometer. Change in concentric knee flexion strength will be assessed from baseline to 4, 8, 12, 18, and 24 weeks after baseline.

    Measured: Measured at all 6 outcome assessments (baseline, 4, 8, 12, 18, and 24 weeks).

  4. Hamstrings:Quadriceps Co-Activation

    Co-activation between the hamstrings and quadriceps muscles will be measured using Delsys surface electromyography sensors during dynamometry, the 6-Minute Walk Test, and the stair climb test. Changes in hamstring:quadriceps co-activation will be assessed from baseline to 4, 8, 12, 18, and 24 weeks after baseline.

    Measured: Measured at all 6 outcome assessments (baseline, 4, 8, 12, 18, and 24 weeks).

  5. 6-Minute Walk Test

    Functional capacity/performance will be assessed using the 6-Minute Walk Test, which measures the distance in meters that a participant can walk in 6 minutes. Changes in performance will be assessed from baseline to 4, 8, 12, 18, and 24 weeks after baseline.

    Measured: Measured at all 6 outcome assessments (baseline, 4, 8, 12, 18, and 24 weeks).

  6. Pain Severity Score

    Pain severity score (from 0 to 40) will be calculated from the pain severity components of the Brief Pain Inventory. The Brief Pain Inventory is a questionnaire that measures the location of pain (body diagram), pain severity (4 questions with numeric rating scales from 0-10, 0 indicating "no pain" and 10 indicating "pain as bad as you can imagine"), medications or treatments, a numeric rating scale (0-100%, 0% indicating "no relief" and 100% indicating "complete relief") for relief of pain from medications or treatments, as well as pain interference (7 questions with numeric rating scales from 0-10, 0 indicating "does not interfere" and 10 indicating "completely interferes"). Changes in pain severity score will be assessed from baseline to 4, 8, 12, 18, and 24 weeks after baseline.

    Measured: Measured at all 6 outcome assessments (baseline, 4, 8, 12, 18, and 24 weeks).

  7. Safety of the Intervention

    Safety of the intervention will be monitored and determined by the number of adverse events reported by participants to either the exercise kinesiologist during the exercise sessions, or to the research team during data collection or via email.

    Measured: Monitored throughout the study from baseline to 24 weeks.

  8. Tolerability of the Intervention

    Tolerability of the exercise intervention will be assessed using the following metrics: Number of participants that withdraw from the study (along with reasons for withdrawal), number of exercises classes completed after 12 weeks, and pain severity (100mm visual analog scale) before and after each exercise class.

    Measured: Monitored throughout the study, from baseline to week 24.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2026
  2. Study start1 Jun 2026 (estimated)
  3. Primary completion1 May 2027 (estimated)
  4. Study completion1 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07626957
Sponsor's protocol ID
REB26-0442
Status last verified
May 2026
First submitted
29 May 2026
Last updated
4 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Progressive resistance exercise with an emphasis on eccentric hamstring loading. in people with Hypermobile EDS (hEDS) and Hypermobile Ehlers-Danlos Syndrome, run by University of Calgary at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ranita Manocha (4039444224, bettermobilitylab@ucalgary.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knee Joint Laxity (time frame: Measured at all 6 outcome assessments (baseline, 4, 8, 12, 18, and 24 weeks).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in